Oh Young Bang/LinkedIn
Nov 9, 2025, 12:28
Oh Young Bang on Enhancement of Post-Stroke Neuroregeneration
Oh Young Bang, Professor of Neurology at Samsung Medical Center, CEO at S and E bio, shared on LinkedIn:
”We’re confirming safety in stroke patients first, then moving on to drug-loaded exosome treatments for neurodegeneration (PMID: 40883738).
The BBB-bypass approach would be key.”
Read the full article here.
Article: Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery
Authors: Ji-Eun Kim, Ye Eun Ji, Hyeon Jun Hwang, Ga-Eun Go, Hyung-Jun Lim, Jaein Yoo, Jooho Kim, Doil Park, Eun Hee Kim, Doory Kim, Oh Young Bang
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 14, 2025, 16:06Dr Abdul Mannan: What’s Your Approach to Diagnosing Iron Deficiency in Tricky Cases?
-
Dec 14, 2025, 16:05Mark Young – 46 Shadow Gates: How Your Chromosomes Archive Ancestral Memory
-
Dec 14, 2025, 16:04NNHF Unveiled at ASH2025: a Bold New Chapter was Marked – Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
-
Dec 14, 2025, 15:46Heghine Khachatryan about PVCS as Cause of Chronic Pelvic Pain and Lower-Extremity/Pelvic Varices in Women
-
Dec 14, 2025, 15:42Gianluca Franceschini – Prevention is the Future: Investing Today to Save Lives Tomorrow
-
Dec 14, 2025, 13:55Indunil Karunarathna: Anticoagulation Therapy in Atrial Fibrillation Risks and Benefits
-
Dec 14, 2025, 12:56Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
-
Dec 14, 2025, 12:54Paul Roscoe: Deeply Proud of the Mend Care Team in This Intervention
-
Dec 13, 2025, 20:23Wolfgang Miesbach: From Daily Pills to Remission after Short‑Course Therapy in ITP